Permanently Discontinued

OCTREOTIDE FOR INJECTABLE SUSPENSION

TEVA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is OCTREOTIDE FOR INJECTABLE SUSPENSION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG has been permanently discontinued (last updated May 6, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is OCTREOTIDE FOR INJECTABLE SUSPENSION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file3 products · 0 same form & route

Affected strength30MG

Report last updated2026-05-06

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

SANDOSTATIN LAR

NOVARTIS PHARMACEUTICALS CANADA INC

30MG · DIN 02239325

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

OCTREOTIDE DEPOT

STERIMAX INC

10MG · DIN 02567776

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

OCTREOTIDE INJECTION

STERIMAX INC

100MCG · DIN 02560240

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02503786

Strength

30MG

Dosage Form

POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT

Route

INTRAMUSCULAR

Active Ingredient

OCTREOTIDE

Tier

Unrated

Last Updated

2026-05-06

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from TEVA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETAMINOPHEN WITH CODEINE - CAPLET

DIN 02143933

DIN 00834319

3.5MG · DIN 02438399

0.5MG · DIN 02301407

100MG · DIN 02420155

200MG · DIN 02420163